Here are three stocks with buy rank and strong value characteristics for investors to consider today, October 17th:
Tailored Brands, Inc. : This specialty apparel retailer has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings advancing 0.4% over the last 60 days.
Tailored Brands, Inc. Price and Consensus
Tailored Brands has a price-to-earnings ratio (P/E) of 9.11 compared with 26.30 for the industry. The company possesses a Value Score of A.
Tailored Brands, Inc. PE Ratio (TTM)
BeldenInc. (BDC - Free Report) : This retailer of footwear has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings increasing 0.3% over the last 60 days.
Belden Inc Price and Consensus
Belden has a price-to-earnings ratio (P/E) of 9.72, compared with 12.30 for the industry. The company possesses a Value Score of A.
Belden Inc PE Ratio (TTM)
Werner Enterprises, Inc. (WERN - Free Report) : This transportation and logistics company has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings advancing 0.9% over the last 60 days.
Werner Enterprises, Inc. Price and Consensus
Werner has a price-to-earnings ratio (P/E) of 14.57, compared with 15.80 for the industry. The company possesses a Value Score of A.
Werner Enterprises, Inc. PE Ratio (TTM)
See the full list of top ranked stocks here
Learn more about the Value score and how it is calculated here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are three stocks with buy rank and strong value characteristics for investors to consider today, October 17th:
Tailored Brands, Inc. : This specialty apparel retailer has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings advancing 0.4% over the last 60 days.
Tailored Brands, Inc. Price and Consensus
Tailored Brands has a price-to-earnings ratio (P/E) of 9.11 compared with 26.30 for the industry. The company possesses a Value Score of A.
Tailored Brands, Inc. PE Ratio (TTM)
BeldenInc. (BDC - Free Report) : This retailer of footwear has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings increasing 0.3% over the last 60 days.
Belden Inc Price and Consensus
Belden has a price-to-earnings ratio (P/E) of 9.72, compared with 12.30 for the industry. The company possesses a Value Score of A.
Belden Inc PE Ratio (TTM)
Werner Enterprises, Inc. (WERN - Free Report) : This transportation and logistics company has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings advancing 0.9% over the last 60 days.
Werner Enterprises, Inc. Price and Consensus
Werner has a price-to-earnings ratio (P/E) of 14.57, compared with 15.80 for the industry. The company possesses a Value Score of A.
Werner Enterprises, Inc. PE Ratio (TTM)
See the full list of top ranked stocks here
Learn more about the Value score and how it is calculated here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on BDC - FREE
Get the latest research report on WERN - FREE